Opus Capital Group, LLC Amgen Inc Transaction History

Opus Capital Group, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$212.27 - $248.7 $232,011 - $271,829	-1,093 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $28,496 - $31,615	-122 Reduced 10.04%	1,093 $266,000
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $51,039 - $59,478	-230 Reduced 15.92%	1,215 $302,000
Q3 2020 Oct 30, 2020	SELL	$234.65 - $260.95 $48,807 - $54,277	-208 Reduced 12.58%	1,445 $367,000
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $4,945 - $6,068	-25 Reduced 1.49%	1,653 $390,000
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $27,336 - $36,255	-150 Reduced 8.21%	1,678 $340,000
Q4 2019 Jan 31, 2020	SELL	$189.21 - $243.2 $1,324 - $1,702	-7 Reduced 0.38%	1,828 $441,000
Q3 2019 Nov 04, 2019	SELL	$174.11 - $208.62 $143,118 - $171,485	-822 Reduced 30.94%	1,835 $355,000
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $8,001 - $9,379	48 Added 1.84%	2,657 $490,000
Q1 2019 Apr 30, 2019	SELL	$180.87 - $203.88 $323,938 - $365,149	-1,791 Reduced 40.7%	2,609 $496,000
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $24,976 - $29,155	-140 Reduced 3.08%	4,400 $857,000
Q3 2018 Nov 06, 2018	SELL	$185.29 - $208.89 $87,086 - $98,178	-470 Reduced 9.38%	4,540 $941,000
Q1 2018 May 04, 2018	SELL	$169.43 - $198.0 $14,062 - $16,434	-83 Reduced 1.63%	5,010 $854,000
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $309,392 - $345,685	1,833 Added 56.23%	5,093 $885,000
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $545,365 - $622,660	3,260	3,260 $607,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Opus Capital Group, LLC with notifications on news.